Death rates in HIV-positive antiretroviral-naive patients with CD4 count greater than 350 cells per μL in Europe and North America: a pooled cohort observational study
- 16 July 2010
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 376 (9738) , 340-345
- https://doi.org/10.1016/s0140-6736(10)60932-4
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Non-AIDS-defining deaths and immunodeficiency in the era of combination antiretroviral therapyAIDS, 2009
- Effect of Early versus Deferred Antiretroviral Therapy for HIV on SurvivalNew England Journal of Medicine, 2009
- Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studiesThe Lancet, 2009
- The role of HIV in serious diseases other than AIDSAIDS, 2008
- Major Clinical Outcomes in Antiretroviral Therapy (ART)–Naive Participants and in Those Not Receiving ART at Baseline in the SMART StudyThe Journal of Infectious Diseases, 2008
- Earlier initiation of antiretroviral therapy in treatment-na??ve patients: implications of results of treatment interruption trialsCurrent Opinion in HIV and AIDS, 2008
- European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of HIV‐infected adultsHIV Medicine, 2008
- Rate of AIDS diseases or death in HIV-infected antiretroviral therapy-naive individuals with high CD4 cell countAIDS, 2007
- Determinants of nevirapine hypersensitivity and its effect on the association between hepatitis C status and mortality in antiretroviral drug-naive HIV-positive patientsAIDS, 2007
- Mortality in Siblings of Patients Coinfected with HIV and Hepatitis C VirusThe Journal of Infectious Diseases, 2007